Kezar Life Sciences repays $6.3M in full, terminates Loan Agreement with Oxford Finance

Kezar Life Sciences, Inc.

Repaid $6.3M in full satisfaction of outstanding amount including accrued interest and exit fees.
Loan and Security Agreement dated Nov 4, 2021 terminated; all liens and security interests released.
Repayment made using cash on hand; no new debt incurred.

item 1.02

Kezar Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-045871

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.